证券代码：600592 证券简称：龙溪股份 公告编号：2025-031 福建龙溪轴承（集团）股份有限公司 九届十次董事会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 福建龙溪轴承（集团）股份有限公司（以下简称"公司"）九届十次董事会 于 2025 年 10 月 15 日以书面形式发出，会议于 2025 年 10 月 20 日以通讯表决方 式召开，本次会议应到董事 7 人，实到董事 7 人，会议程序符合《中华人民共和 国公司法》（以下简称《公司法》）和《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过《关于取消监事会暨修订公司章程的议案》； 具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn）披露的《龙 溪股份关于取消监事会暨修订公司章程的公告》（公告编号：2025-032）。 本次修订《公司章程》的事项尚需提交公司股东大会审议。公司董事会提请 股东大会授权董事会及其授权人士办理变更登记、章程备案等相关事宜。上述变 更登记及章程备案最终以市场监督管理部门核准通过的 ...

福建龙溪轴承（集团）股份有限公司 股东会议事规则（2025 年 10 月修订） 福建龙溪轴承（集团）股份有限公司 股东会议事规则 （尚需提交股东大会审议） 第一章 总 则 第二条 公司股东会的召集、提案、通知、召开等事项适用本规则。 第三条 公司应当严格按照法律、行政法规、本规则及《公司章程》的相关 规定召开股东会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当 勤勉尽责，确保股东会正常召开和依法行使职权。 第四条 公司股东会应当在《公司法》和《公司章程》规定的范围内行使职 权。 第五条 公司股东会分为年度股东会和临时股东会。年度股东会每年召开一 次，应当于上一会计年度结束后的六个月内举行。 临时股东会不定期召开，出现下列情形之一的，公司应当在事实发生之日起 在两个月内召开临时股东会： （一）董事人数不足《公司法》规定人数或者《公司章程》所定人数的三分 之二时； 第一条 为进一步规范福建龙溪轴承（集团）股份有限公司（以下简称公司） 行为，保证股东会依法行使职权，根据《中华人民共和国公司法》（以下简称《公 司法》）、《中华人民共和国证券法》（以下简称《证券法》）、 ...

第一章 总则 第一条 为建立符合现代企业制度要求的激励和约束机制，合理确定公司董事 长、经理班子收入水平，有效调动董事长、经理班子的积极性与创造性，提高公司管 理水平和运营效率，实现公司资产和股东权益的保值增值，根据《公司法》、《公司章 程》和各级政府、国资委有关规定，特制定本办法。 第二条 年薪制是指以企业的年度经营业绩和任期经营业绩确定董事长、经理班 子年薪的分配激励制度。年薪是指董事长、经理班子在年度内和任期内获取的全部工 资性收入，由三部分组成：基本年薪、绩效年薪和任期激励收入。 第三条 董事长、经理班子薪酬管理的基本原则： 1、薪酬与业绩挂钩原则。董事长、经理班子的年薪收入与经营业绩紧密挂钩， 强化董事长、经理班子责任，激发企业发展活力。 福建龙溪轴承（集团）股份有限公司 董事长、经理班子薪酬管理办法（2025 年 10 月修订） 福建龙溪轴承（集团）股份有限公司 董事长、经理班子薪酬管理办法 （尚需提交股东大会审议） 2、薪酬与责任、风险相一致的原则。董事长、经理班子的年薪收入与其承担的 责任、风险相联系，责任与风险成正比。 3、体现按劳分配、效益优先、兼顾公平原则。本办法以提高经营管理效率和经 ...

Core Viewpoint - Longxi Co., Ltd. has experienced a significant stock price increase of 149.20% year-to-date, but has recently faced a decline of 9.00% over the past five trading days and 15.66% over the past twenty days [1] Group 1: Stock Performance - As of October 17, Longxi's stock price was reported at 24.26 CNY per share, with a market capitalization of 9.693 billion CNY [1] - The stock has seen a trading volume of 52.39 million CNY, with a turnover rate of 0.54% [1] - The company has appeared on the "龙虎榜" (a stock trading list) seven times this year, with the most recent appearance on May 19, where it recorded a net buy of -854.08 million CNY [1] Group 2: Financial Performance - For the first half of 2025, Longxi reported a revenue of 745 million CNY, a year-on-year decrease of 18.57%, while the net profit attributable to shareholders was 64.76 million CNY, a year-on-year increase of 0.61% [2] - The company's main business revenue composition includes bearing products (62.11%), metal material trading (32.42%), and other segments [1] Group 3: Shareholder Information - As of June 30, 2025, Longxi had 58,000 shareholders, an increase of 67.83% from the previous period, with an average of 6,892 circulating shares per shareholder, a decrease of 40.41% [2] - The top ten circulating shareholders include new entrants such as Yongying Advanced Manufacturing Mixed Fund and Penghua Carbon Neutral Theme Mixed Fund [3]

Core Viewpoint - Longxi Co., Ltd. has experienced significant stock price fluctuations, with a year-to-date increase of 166.36% but a recent decline in the last five and twenty trading days [1][2]. Financial Performance - For the first half of 2025, Longxi Co., Ltd. reported operating revenue of 745 million yuan, a year-on-year decrease of 18.57%, while net profit attributable to shareholders was 64.76 million yuan, a slight increase of 0.61% [2]. - Cumulatively, the company has distributed 876 million yuan in dividends since its A-share listing, with 109 million yuan distributed over the past three years [3]. Stock Market Activity - As of October 14, 2023, Longxi Co., Ltd.'s stock price was 25.93 yuan per share, with a market capitalization of 10.36 billion yuan [1]. - The stock has appeared on the "龙虎榜" (a trading board for stocks with significant trading activity) seven times this year, with the most recent appearance on May 19, 2023, showing a net buy of -854.08 million yuan [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders increased by 67.83% to 58,000, with an average of 6,892 circulating shares per person, a decrease of 40.41% [2]. - Notable institutional shareholders include Yongying Advanced Manufacturing Mixed Fund and Penghua Carbon Neutral Theme Mixed Fund, both of which are new entrants among the top ten circulating shareholders [3].

Investment Rating - The report suggests a focus on the robotics industry, particularly on whole machine manufacturers and core component suppliers, with an overall investment rating of "Neutral" for the industry [26]. Core Insights - The humanoid robotics sector is experiencing a dual momentum of "technological deepening" and "scene landing," indicating a positive outlook for the robotics industry [2]. - Google has launched the latest Gemini Robotics 1.5 series, enhancing robot autonomy and task execution capabilities through advanced models [4][16]. - The report highlights significant investment opportunities in various segments of the robotics supply chain, including motors, joints, sensors, and more [18]. Summary by Sections Industry News and Company Dynamics - Jiangsu Donghua Testing Technology Co., Ltd. signed a strategic cooperation agreement with Nantong Zhenkang Machinery Co., Ltd. to enhance collaboration in robotic joint module technology [6]. - Fourier's third-generation humanoid robot GR-3C made its debut at the 2025 Industrial Expo, showcasing advanced design and capabilities [7]. Investment and Financing Dynamics - 1X Robotics is seeking to raise up to $1 billion, aiming for a valuation of at least $10 billion, following the launch of its new home robot Neo Gamma [16]. - Quan Zhibo completed two rounds of financing exceeding 100 million yuan, focusing on talent development and R&D [16]. Investment Recommendations - The report recommends focusing on key robotics component suppliers, including: 1. Motors: Mingzhi Electric 2. Rotating joints: Zhongchen Technology, Shuanghuan Transmission, Landai Technology 3. Linear joints: Hengli Hydraulic 4. Dexterous hands: Zhaowei Electromechanical 5. Encoders: Yap Technology, Fengqiao Technology 6. Sensors: Donghua Testing, Keli Sensor, Anpeilong, Hanwei Technology 7. Screw equipment: Qinchuan Machine Tool, Huachen Equipment 8. Bearings: Longxi Co., Ltd. [18][19]

Group 1 - Longxi Co., Ltd. announced the resignation of Mr. Zeng Sixin from his positions as director, financial director, board secretary, and member of the board's special committee due to tenure reasons [1] - Following his resignation, Mr. Zeng Sixin will no longer hold any other positions within the company [1] Group 2 - Related companies such as Reader Media, CITIC Heavy Industries, and Huiyun Titanium Industry have recently appointed new financial directors [2]

Group 1 - The board of directors of Fujian Longxi Bearing (Group) Co., Ltd. held its ninth meeting on September 25, 2025, via communication voting, with all 7 directors present, and the meeting procedures complied with the Company Law and the Articles of Association [2][4] - The board approved the proposal to appoint Vice General Manager Huang Jie to act as the Secretary of the Board until a formal appointment is made [3][10] - The board also approved the proposal to appoint Vice General Manager Shen Haishi to act as the Chief Financial Officer until a formal appointment is made [5][10] Group 2 - The resignation of former director, CFO, and Secretary of the Board, Zeng Sixin, was accepted due to work adjustments related to his tenure, and his resignation does not affect the board's normal operations [11] - The company will expedite the selection process for the CFO and Secretary of the Board in accordance with legal procedures [11][10] - Huang Jie and Shen Haishi's interim roles are aimed at ensuring the continuity of board operations and financial management [11]

Group 1: Investment and Fundraising - Hanyu Pharmaceutical plans to raise no more than 968 million yuan for the development of semaglutide and other projects [1] - Ganfeng Lithium intends to introduce investors for a capital increase of up to 2.5 billion yuan [9] Group 2: Strategic Restructuring - Pingmei Shenma Holdings is undergoing a strategic restructuring as directed by the Henan provincial government, which will not affect the company's operations significantly [2][8] - Shennong Holdings is also involved in a strategic restructuring with no change in control or significant impact on operations [7][8] Group 3: Clinical Trials and Approvals - XinNuoWei's subsidiary received approval for clinical trials of a drug for treating mild Alzheimer's disease, marking a significant milestone in the development of biosimilar drugs [3] - Tainkang's subsidiary has received approval for clinical trials of CKBA cream for rosacea, a first-class innovative drug in China [4] - Baili Tianheng's drug, iza-bren, has been included in the list of breakthrough therapies, indicating its potential in treating advanced urinary tract cancer [5] Group 4: Contracts and Projects - Zhongyou Engineering signed an EPC contract worth 2.524 billion USD for a seawater pipeline project in Iraq, expected to positively impact future revenues [6]

证券代码：600592 证券简称：龙溪股份 公告编号：2025-030 福建龙溪轴承（集团）股份有限公司 关于董事、财务总监兼董事会秘书离任暨后续履职安排 的公告 | | | | | | 是否继续在上 | | 是否存在 | | --- | --- | --- | --- | --- | --- | --- | --- | | 姓名 | 离任职务 | 离任时间 | 原定任期 | | | 具体职务 | 未履行完 | | | | | 到期日 | 离任原因 | 市公司及其控 股子公司任职 | （如适用） | 毕的公开 | | | | | | | | | 承诺 | | 曾四新 | 董事、财务 总监、董事 | | | 因任职年 | | | | | | 会秘书、董 | 2025 年 9 | 2027年9月 | 限原因， | 否 | 不适用 | 否 | | | 事会专门 | 月 24 日 | 12 日 | 进行工作 | | | | | | 委员会委 | | | 调整 | | | | | | 员 | | | | | | | 二、董事、财务总监兼董事会秘书离任对公司的影响 根据《中华人民共和国公司法》《公司章程》等相关规定，曾四 ...